Chemotherapy-refractory diffuse large B-cell lymphoma and indolent B-cell malignancies can be effectively treated with autologous T cells expressing an anti-CD19 chimeric antigen receptor (Q34041792)
scientific article
Language:
(P31) (Q13442814)
(P50) (Q2347448)
(P304) 540-549
(P407) (Q1860)
(P433) 6
(P478) 33
(P577) Monday, August 25, 2014
(P921) (Q974135)
(Q4833719)
(Q2626074)
(P1433) (Q400292)
(P1476) "Chemotherapy-refractory diffuse large B-cell lymphoma and indolent B-cell malignancies can be effectively treated with autologous T cells expressing an anti-CD19 chimeric antigen receptor" (language: en)
(P2093) James N Kochenderfer
Mark E Dudley
Sadik H Kassim
Robert P T Somerville
Robert O Carpenter
Maryalice Stetler-Stevenson
James C Yang
Giao Q Phan
Marybeth S Hughes
Richard M Sherry
Mark Raffeld
Steven Feldman
Lily Lu
Yong F Li
Lien T Ngo
Andre Goy
Tatyana Feldman
David E Spaner
Michael L Wang
Clara C Chen
Sarah M Kranick
Avindra Nath
Debbie-Ann N Nathan
Kathleen E Morton
Mary Ann Toomey
(P2860) (Q29617590)
(Q37418289)
(Q38146506)
(Q38141522)
(Q37390239)
(Q37263151)
(Q38123667)
(Q34036213)
(Q38094968)
(Q29620130)
(Q29620607)
(Q27312288)
(Q36778126)
(Q38066901)
(Q36475411)
(Q37981536)
(Q29620717)
(Q37967335)
(Q29622949)
(Q24632975)
(Q24594920)
(Q34876434)
(Q34627748)
(Q34360292)
(Q34310912)
(Q37625597)
(Q37354362)
(Q24616084)
(Q24540135)
(Q29615097)
(Q28215003)
(Q28146072)
(Q36070000)
(Q36346300)
(Q44841161)
(Q46367197)
(Q42938990)
(Q47582438)
(Q44794043)
(Q53659254)
(Q47567565)
(Q68090182)
(Q69548004)
(Q67885607)
(Q83689509)
(Q86044024)
other details
description scientific article

External Links